.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chubb
Federal Trade Commission
McKesson
Harvard Business School
Dow
Daiichi Sankyo
Colorcon
Boehringer Ingelheim
Mallinckrodt

Generated: November 19, 2017

DrugPatentWatch Database Preview

Silvergate Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SILVERGATE PHARMS, and what generic alternatives to SILVERGATE PHARMS drugs are available?

SILVERGATE PHARMS has four approved drugs.

There are six US patents protecting SILVERGATE PHARMS drugs on SILVERGATE PHARMS drugs in the past three years.

There are seven patent family members on SILVERGATE PHARMS drugs in four countries.

Summary for Silvergate Pharms

International Patents:7
US Patents:6
Tradenames:4
Ingredients:3
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Silvergate Pharms
EPANED KIT
enalapril maleate
FOR SOLUTION;ORAL204308-001Aug 13, 2013RXYesYes► Subscribe► Subscribe ► Subscribe
Silvergate Pharms
QBRELIS
lisinopril
SOLUTION;ORAL208401-001Jul 29, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Silvergate Pharms
EPANED
enalapril maleate
SOLUTION;ORAL208686-001Sep 20, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Silvergate Pharms
XATMEP
methotrexate sodium
SOLUTION;ORAL208400-001Apr 25, 2017RXYesYes► Subscribe► Subscribe► Subscribe
Silvergate Pharms
EPANED KIT
enalapril maleate
FOR SOLUTION;ORAL204308-001Aug 13, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Silvergate Pharms
QBRELIS
lisinopril
SOLUTION;ORAL208401-001Jul 29, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Silvergate Pharms
XATMEP
methotrexate sodium
SOLUTION;ORAL208400-001Apr 25, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SILVERGATE PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
enalapril maleate
Powder for Oral Solution1 mg/mL
EPANED KIT
6/21/2016

International Patent Family for Silvergate Pharms Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014055667► Subscribe
European Patent Office2903690► Subscribe
United Kingdom201200192► Subscribe
European Patent Office2614814► Subscribe
World Intellectual Property Organization (WIPO)2017161339► Subscribe
World Intellectual Property Organization (WIPO)2017075368► Subscribe
Canada2887379► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Colorcon
Healthtrust
Chinese Patent Office
Moodys
McKinsey
QuintilesIMS
Accenture
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot